The global muscle tension dysphonia treatment market was anticipated to reach a valuation of USD 13.2 Billion in the year 2022. With a steady CAGR of 3.1% from 2023 to 2033, this market is expected to reach USD 13.61 Billion by 2023 and USD 18.47 Billion by 2033.
There is often an initiating event for muscular tension dysphonia, which manifests as strained voice quality. These things might be:
Muscle tension dysphonia is extremely uncommon both in its frequency and prevalence. According to data from the National Spasmodic Dysphonia Association, there might be between 10,000 and 30,000 afflicted people in the United States. The market for treatments for muscle tension dysphonia is expected to grow as a result of factors including:
As the years go by, more and more therapy options for muscular tension dysphonia are becoming accessible, which will aid in the patients' quicker recovery. Therapies include voice therapy, swallow therapy, singing therapy, and other surgical procedures are all advancing in terms of treatment. As a result, it significantly contributes to the expansion of the market for treating muscular tension dysphonia. The market is expanding because more research and development efforts are being conducted.
The market for treatments for muscular tension dysphonia will benefit from these prospects. The government is sponsoring research and development (R&D) activities to entice scientists and pharmaceutical businesses to create innovative medications. Such developments are expected to boost the demand for muscle tension dysphonia treatments during the forecast period, 2023 to 2033.
The expansion will also be fueled by rising demand for specialized and customized diagnostic techniques. For this illness, there are no particular diagnostic methods available. The laryngologist as well as speech-language pathologist base their diagnosis on the patient's account of the symptoms they are experiencing, the sound of their voice, and their examination of the vocal folds when they speak.
Opportunities for market expansion are created by the usage of various medications for muscular tension dysphonia that are distributed through retail pharmacies and by the expanding number of retail pharmacies in economically developed nations. Patients often like retail pharmacies since they may simply access the medications there.
Various therapies are being developed by government medical facilities to enhance the treatment procedure globally. For instance, the University of British Columbia conducted a Phase 2 Study of Deep Brain Stimulation (DBS) for muscle tension dysphonia in 2021. Electrodes are implanted during a neurosurgery technique called deep brain stimulation to administer electrical stimulation to particular parts of the brain.
For many other movement related disorders such as Parkinson's disease as well as generalized dystonia, it serves as the gold standard surgical therapy. An electrode is carefully put into the brain throughout a DBS treatment and connected to a pacemaker that is installed beneath the skin of the patient’s chest or even the abdominal wall.
When this pacemaker is wholly activated, a very tiny electric current enters the brain and stops the harmful messages that are the cause of the illness. Such factors are anticipated to accelerate the global growth for muscle tension dysphonia treatment during the forecast period.
| Data Point | Key Statistics |
|---|---|
| Expected Market value in 2023 | USD 13.61 Billion |
| Expected Market value in 2033 | USD 18.47 Billion |
| Growth Rate (2023 to 2033) | 3.1% |
Muscle tension dysphonia is an imbalance in the management of the muscles and breathing patterns need to create voice. Muscle tension dysphonia can be associated with stress and anxiety. This often occurs following an upper respiratory illness such as flu or cold.
Common symptoms associated with muscle tension dysphonia are inconsistent voice, inability to sing, breaking voice, unreliable voice, airy or breathy voice, vocal fatigue, hoarse and rough quality voice, etc.
Muscle tension dysphonia market is expanding with the increasing incidence of voice disorders. There are various diagnostic tests in the muscle tension dysphonia treatment market such as laryngoscopy and stroboscopy, speech-language pathology evaluation and also investigation for other associated abnormalities.
Voice therapy and behavioural counselling are the treatment widely used for treating muscle tension dysphonia. Voice therapy is the most effective treatment in the muscle tension dysphonia treatment market that can restore the muscle balance in the vocal mechanism.
During this COVID-19 pandemic, pharmaceutical companies, medical devices companies and also biotechnology companies are facing rapid challenges that are arising from the disruption in supply chains and the need to change business processes.
The flow of patients into the hospitals and clinics have been reduced as a result the number of muscle tension dysphonia treatment therapy performed is reduced. There is lack of interest by government promoting voice therapy due to the, since the whole focus is shifted to coronavirus.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising incidence of voice disorders among children and adults is likely to drive the market of muscle tension dysphonia treatment market. Rising stress is the major driver of muscle tension dysphonia treatment market. Moreover, increasing chronic diseases such as autism, Parkinson’s disease, brain injuries, tumors, cerebral palsy and stroke are expected to boost up the muscle tension dysphonia market.
Increasing demand for effective voice therapy is also driving the growth of muscle tension dysphonia treatment market. Initiatives by the government for promoting voice therapy and increasing healthcare expenditure in various regions are other factors boosting muscle tension dysphonia treatment market.
Apart from drivers, many factors restraining the growth of the muscle tension dysphonia treatment market. Lack of proper access to healthcare facilities is limiting the growth of muscle tension dysphonia treatment market. The insufficient number of healthcare professionals and tools for the diagnosis and treatment for voice disorders are the major restraints of muscle tension dysphonia market.
Based on the age group, the adult group is expected to be the largest segment in the global muscle tension dysphonia treatment market. It usually occurs in the age group 30-50. Based on the distribution channel, hospitals are expected to be the most profitable segment in the muscle tension dysphonia treatment market.
Principal Consultant
North America and Europe are expected to dominate the global muscle tension dysphonia treatment market, owing to a rise in the patient population, an increase in various voice disorders and high awareness about voice therapy.
Increasing healthcare expenditure, awareness and lifestyle changes in the developing region like Asia-Pacific is expected to drive the global muscle tension dysphonia treatment market growth over the forecast period. Rising population in countries like India and China is further likely to drive the growth of the muscle tension dysphonia treatment market.
Some of the market participants in the global Muscle tension dysphonia treatment market identified across the value chain include:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Treatment Type 6.2. Age Group 6.3. Distribution Channel 7. Global Market Analysis and Forecast, By Treatment Type 7.1. Drugs 7.2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) 7.3. Proton-Pump Inhibitors 7.4. Analgesics 7.5. Antacids 7.6. Voice Therapy 7.7. Behavioral Counseling 8. Global Market Analysis and Forecast, By Age Group 8.1. Pediatrics 8.2. Adults 8.3. Elderly 9. Global Market Analysis and Forecast, By Distribution Channel 9.1. Institutional Sales 9.2. Hospitals 9.3. Clinics 9.4. Specialized Centers 9.5. Retail Sales 9.6. Retail Pharmacies 9.7. Online Pharmacies 9.8. Drug Store 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Asia Pacific 10.5. China 10.6. Japan 10.7. Middle East and Africa 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 15. China Sales Analysis and Forecast, by Key Segments and Countries 16. Japan Sales Analysis and Forecast, by Key Segments and Countries 17. Middle East and Africa Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Treatment Type, Age Group, and Distribution Channel for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Teva Pharmaceutical Pvt. Ltd. 20.2. Pfizer Inc. 20.3. Cipla Inc. 20.4. Therapy Solutions LLC 20.5. Smart Speech 20.6. Benchmarl Therapies Inc. 20.7. Speech Plus 20.8. Talk Speech and Language Therapy Ltd 20.9. Smart Speech Therapy LLC 20.10. Integrated Treatment Services 20.11. Speechworks Therapy Services 20.12. Therapy Ltd 20.13. Glenda Brown Speech Pathology
Explore Healthcare Insights
View Reports
Muscle Tension Dysphonia Treatment Market
